We warmly invite you to take advantage of exclusive special rates.

Today’s newsletter brings you hand-picked highlights from Vienna’s life sciences community and invites you to explore…

Our latest newsletter brings you a curated selection of life sciences updates, current funding opportunities, and event…

_.

As always, our latest newsletter is packed with news from Vienna’s life sciences sector, upcoming events, and current…

Learn more in this article about the efforts to develop a low-side-effect compound for the treatment of neuropsychiatric…

Feiern Sie mit und profitieren Sie von einem exklusiven Jubiläumsangebot.

Vienna continues to lead the way in life sciences, driving innovation in biotech, pharma, and medtech. In this edition,…

As the holidays are just around the corner, we close the year with this last edition of our newsletter. We're excited to…

On November 28, Takeda hosted its second R&D Science Day in collaboration with LISAvienna. The event aimed to bring…

We are delighted to share a selection of photos from this year’s BIO-Europe event!

Have a look at our curated list of news items, events and funding opportunities.

Christoph Rademacher, Professor of Molecular Drug Targeting at the University of Vienna, founded Cutanos in Vienna in…

Today’s newsletter updates you on LISAvienna’s new office at Karl-Farkas-Gasse 18, 1030 Vienna, our new phone numbers as…

Hier finden Sie ausgewählte Fotos von der Veranstaltung am 17.10.2024 im Apothekertrakt, Schloss Schönbrunn.

Am 17. Oktober 2024 versammelten sich bei der #REG24 in Wien rund 400 Fachleute aus dem DACH-Raum, um sich über wichtige…

Dive into the latest news and updates from Vienna’s thriving life sciences sector.

LISAvienna is happy to collaborate with Takeda and invites you to participate in the second Takeda R&D Science Day in…

Learn more about the last weeks’ highlights, upcoming event and opportunities for funding and support.

Flagship projects play a central role in the implementation of the Vienna 2030 – Economy and Innovation strategy. To…

Today's mailing provides information about news from the Viennese life sciences sector, events, support offers and…

We are supporting the survey of companies and research institutions in the Austrian life sciences sector, which is…

Boehringer Ingelheim, one of the top pharmaceutical companies in Europe, is actively supporting the next generation of…

Defined as a flagship project as part of the Vienna 2030 economic and innovation strategy, the establishment of QMD…

Osteoarthritis is a painful, chronic joint disease. Supported by wings4innovation, the KHAN-I Fund is providing…

Enjoy the reading!

We’re pleased to share a selection of photos with you.

Thank you for attending the reception at Vienna City Hall prior to The MedTech Forum 2024.

We’re pleased to share a selection of life sciences news from Vienna with you again. Among others, we put headlines from…

In collaboration with LISAvienna and the IMP, Boehringer Ingelheim runs this initiative to tighten the company’s…

For the future of Vienna as a business and innovation location, it is important to familiarize children and young people…

It's newsletter season at LISAvienna, and we're thrilled to share a few updates from life sciences research institutions…

An important ingredient in Vienna’s recipe for success as a location for business and innovation is the continuous…

Today we are highlighting news from selected companies and research institutions, including Biomay, Danaher, G.ST…

2024, LISAvienna will present selected flagship projects from the VIENNA 2030 business and innovation strategy and…

We are pleased to draw your attention to our last newsletter of this year. Read it online now!

Bringing innovators and scientists under one roof

LISAvienna is a member of CEBR, and we encourage you to complete a short questionnaire online (max. 5 minutes…

In September, Roche organized its inaugural Roche Open Innovation Day in collaboration with LISAvienna. The idea was to…

We cover highlights from companies and research institutions including Biomay, cogvis, contextflow, FH Campus Wien,…

Diese Frage wurde im Rahmen unserer LISAvienna Regulatory Konferenz für Medizinprodukte und In-vitro Diagnostika am 17.…

Am 17.10.2023 diskutierten hochrangige Referent*innen bei der LISAvienna Regulatory Konferenz zu dieser Frage. Die…

Here we provide you with the link to read our newsletter in your browser. News items from BOKU, Hookipa Pharma, BlueSky…

Hier finden Sie ausgewählte Fotos von der Veranstaltung im Apothekertrakt, Schloss Schönbrunn.

Look forward to an overview of selected news from Vienna, events and funding opportunities. This time the focus is on…

LISAvienna is pleased to collaborate with Takeda and invites you to join the first "Takeda R&D in Focus" event on…

Life sciences expert Eva Schlintl joined the LISAvienna team on September 1, 2023. Take advantage of industry events in…

Enjoy reading today’s update on a selection of recent news items from Vienna’s life sciences community. We for example…

Enjoy our update on recent life sciences news from Vienna

LISAvienna is happy to collaborate with Roche Pharma in Austria and invites you to participate in the company’s first…

Our highlights in this edition are the news items from Takeda, Marinomed, Biome Diagnostics, University of Vienna,…

Hier finden Sie ausgewählte Fotos von der Veranstaltung am 9.5.2023 im Palais Niederösterreich in Wien

Erster Austrian Life Science Day - Thematische Förderprogramme entwickeln die Branche gezielt weiter - Resilienz des…

Today we highlight recent success stories from Arkeon, Boehringer Ingelheim, enGenes, invIOs, piur imaging, Proxygen,…

On April 19, Takeda hosted its first R&D Science Day in collaboration with LISAvienna. The event was aimed at start-ups…

On March 7, 2023, Boehringer Ingelheim’s experts were available for the “Office Hours” hosted at the IMP in Vienna. Five…

Today we are pleased to present you again an overview with selected news that reached us from the Viennese life sciences…

We highlight interesting news from Arkeon, Boehringer Ingelheim, contextflow, Evercyte, Hookipa Pharma, IVI, MedUni…

We invite all young life sciences companies from across Austria to apply by February 15, 2023!

- Technologieexpert*in Life Sciences, Vollzeit (40h)